Sunshine Biopharma Inc. Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax
Sunshine Biopharma Inc. (SBFM) reported Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax of $0 for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-05.
Financial Statements › Income Statement › Other Income
us-gaap:UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax · last filed 2024-11-05
- Sunshine Biopharma Inc. unrealized gain (loss) on foreign currency derivatives, net, before tax for the quarter ending 2023-12-31 was -$374.00.
- Sunshine Biopharma Inc. unrealized gain (loss) on foreign currency derivatives, net, before tax for the quarter ending 2023-09-30 was $374.00.
- Sunshine Biopharma Inc. unrealized gain (loss) on foreign currency derivatives, net, before tax for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. unrealized gain (loss) on foreign currency derivatives, net, before tax for the quarter ending 2023-03-31 was $0.00.
- Sunshine Biopharma Inc. unrealized gain (loss) on foreign currency derivatives, net, before tax for fiscal 2023 was $0.00.
- Sunshine Biopharma Inc. unrealized gain (loss) on foreign currency derivatives, net, before tax for fiscal 2022 was -$548.00, a 1196.00% decline from fiscal 2021.
- Sunshine Biopharma Inc. unrealized gain (loss) on foreign currency derivatives, net, before tax for fiscal 2021 was $50.00, a 98.98% decline from fiscal 2020.
- Sunshine Biopharma Inc. unrealized gain (loss) on foreign currency derivatives, net, before tax for fiscal 2020 was $4.89K.
| Period end | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 3 month | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 3 month as first filed | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 6 month | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 9 month | Unrealized Gain (Loss) on Foreign Currency Derivatives, Net, before Tax 12 month |
|---|---|---|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2024-11-05 | ||||
| 2023-12-31 | -$374.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $0.00 derived: sum of 2 quarters · filed 2024-11-05 | $0.00 derived: sum of 3 quarters · filed 2024-11-05 | $0.00 10-K · filed 2024-03-28 | |
| 2023-09-30 | $374.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $374.00 derived: sum of 2 quarters · filed 2024-11-05 | $374.00 10-Q · filed 2024-11-05 | -$129.00 derived: sum of 4 quarters · filed 2024-11-05 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | -$503.00 derived: sum of 3 quarters · filed 2024-03-28 | -$568.00 derived: sum of 4 quarters · filed 2024-03-28 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | -$503.00 derived: sum of 2 quarters · filed 2024-03-28 | -$568.00 derived: sum of 3 quarters · filed 2024-03-28 | -$539.00 derived: sum of 4 quarters · filed 2024-03-28 | |
| 2022-12-31 | -$503.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$568.00 derived: sum of 2 quarters · filed 2024-03-28 | -$539.00 derived: sum of 3 quarters · filed 2024-03-28 | -$548.00 10-K · filed 2024-03-28 | |
| 2022-09-30 | -$65.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$36.00 derived: sum of 2 quarters · filed 2023-11-13 | -$45.00 10-Q · filed 2023-11-13 | -$26.00 derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $29.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $20.00 10-Q · filed 2023-08-10 | $39.00 derived: sum of 3 quarters · filed 2023-08-10 | $64.00 derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | -$9.00 10-Q · filed 2023-05-10 | $10.00 derived: sum of 2 quarters · filed 2023-05-10 | $35.00 derived: sum of 3 quarters · filed 2023-05-10 | $55.00 derived: sum of 4 quarters · filed 2023-05-10 | |
| 2021-12-31 | $19.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-04 | $44.00 derived: sum of 2 quarters · filed 2023-04-04 | $64.00 derived: sum of 3 quarters · filed 2023-04-04 | $50.00 10-K · filed 2023-04-04 | |
| 2021-09-30 | $25.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $45.00 derived: sum of 2 quarters · filed 2022-11-07 | $31.00 10-Q · filed 2022-11-07 | -$1.48K derived: sum of 4 quarters · filed 2022-11-07 | |
| 2021-06-30 | $20.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $6.00 10-Q · filed 2022-08-03 | -$1.51K derived: sum of 3 quarters · filed 2022-08-03 | ||
| 2021-03-31 | -$14.00 10-Q · filed 2022-05-06 | -$1.53K derived: sum of 2 quarters · filed 2022-05-06 | |||
| 2020-12-31 | -$1.51K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $4.89K 10-K · filed 2022-03-21 | |||
| 2020-09-30 | $6.40K 10-Q · filed 2021-11-09 | ||||
| 2019-09-30 | -$115.00 10-Q · filed 2019-11-13 | $2.38K derived: sum of 2 quarters · filed 2019-11-13 | $1.60K 10-Q · filed 2019-11-13 | ||
| 2019-06-30 | $2.50K 10-Q · filed 2019-08-15 | $1.71K 10-Q · filed 2019-08-15 | |||
| 2019-03-31 | -$785.00 10-Q · filed 2019-05-20 | ||||
| 2018-09-30 | $12.00K 10-Q · filed 2019-11-13 | $11.50K 10-Q · filed 2018-11-16 | $7.95K derived: sum of 2 quarters · filed 2019-11-13 | $3.23K 10-Q · filed 2019-11-13 | |
| 2018-06-30 | -$4.06K 10-Q · filed 2019-08-15 | -$5.79K 10-Q · filed 2019-08-15 | |||
| 2018-03-31 | -$2.74K 10-Q · filed 2019-05-20 | ||||
| 2017-09-30 | $4.33K 10-Q · filed 2018-11-16 | $7.01K derived: sum of 2 quarters · filed 2018-11-16 | $8.13K 10-Q · filed 2018-11-16 | ||
| 2017-06-30 | $2.68K 10-Q · filed 2018-08-17 | $3.79K 10-Q · filed 2018-08-17 | |||
| 2017-03-31 | $1.51K 10-Q · filed 2018-05-22 | ||||
| 2016-09-30 | -$305.00 10-Q · filed 2017-11-15 | $11.02K derived: sum of 2 quarters · filed 2017-11-15 | $1.03K 10-Q · filed 2017-11-15 | ||
| 2016-06-30 | $11.32K 10-Q · filed 2017-08-11 | -$1.33K 10-Q · filed 2017-08-11 | |||
| 2016-03-31 | -$9.99K 10-Q · filed 2017-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |